ACHP Statement on Drug Pricing
ACHP released a statement on drug pricing.
04/18/2025
Securing Affordable Treatments for All Americans
Anticompetitive practices within the pharmaceutical industry, coupled with outdated patent laws that inhibit more affordable biosimilars and generics, have resulted in skyrocketing drug costs for all Americans – but especially seniors and those with chronic conditions. ACHP advocates for sensible policies such as price transparency to rein in sky-high costs so that patients can afford the medications they need.
Recent
Ending the Allure of Drug Advertising
ACHP calls on Congress to curb direct-to-consumer (DTC) drug ad …
04/10/2025
ACHP Statement on Final CY2026 MA and Part D Rule
ACHP President and CEO Ceci Connolly released a statement in …
04/04/2025
ACHP Letter to CMS Administrator Dr. Oz
ACHP sent a letter to CMS Administrator, Dr. Oz, with …
04/04/2025
ACHP Statement on Dr. Oz’s Confirmation as CMS Administrator
ACHP is grateful for its longstanding partnership with CMS and …
04/03/2025
Featured
OP-ED: What Could We Do if GLP-1 Weight Loss Drugs Were Free? Would Our Obesity Epidemic Be Solved for Good?
ACHP President and CEO Ceci Connolly coauthored an op-ed examining …
04/10/2024
PBMs are Clear as Mud: The Value of a Fee-Based, Transparent Model
Transparency in the drug supply chain is desperately needed to …
03/24/2025
Report Finds Improved Health & Greater Savings When Patients Take Their Medications as Prescribed
When people with diabetes follow their prescribed medical regimens, they …
11/10/2023
Sleeping Giants: How Employers Can Shape the Future of Health Care
Morgan Health CEO Dan Mendelson joins the Healthy Dialogue podcast …
09/13/2022
ACHP Applauds Senate Passage of Inflation Reduction Act
ACHP applauds the Senate for passing the Inflation Reduction Act, …
08/07/2022
Letter to Congressional Leadership on Ways to Improve Affordability in Health Care
The Alliance of Community Health Plans has sent Congressional Leaders …
04/25/2022
Ending the Allure of Drug Advertising
ACHP calls on Congress to curb direct-to-consumer (DTC) drug ad …
04/10/2025
Resource Library Search
Search by
Ending the Allure of Drug Advertising
ACHP calls on Congress to curb direct-to-consumer (DTC) drug ad dominance. Patients should be able to access affordable, necessary medications, rather than being swayed by misleading marketing tactics.
04/10/2025
ACHP Letter to Dr. Oz on Deregulation in Health Insurance
ACHP sent a letter to Dr. Mehmet Oz with commonsense reforms that cut unnecessary red tape and save precious health care dollars.
04/10/2025
ACHP Comments on CMS Marketplace Integrity & Affordability Proposed Rule
ACHP comments on the CMS Marketplace Integrity and Affordability Proposed Rule.
04/10/2025
ACHP Statement on CY2026 MA and Part D Rate Notice
ACHP commends the Trump Administration for finalizing policies in the 2026 MA and Part D Rate Notice that reflect higher care delivery costs and for taking another step toward reining …
04/07/2025
Loading…
